SKIN

SkinHealth Systems Inc. (SKIN) shares jumped 9% following completion of a 1-for-20 reverse stock split on October 14, 2026, which helped the company regain compliance with Nasdaq's minimum bid price requirement. However, the company faces significant headwinds with expected quarterly losses of $1.35 per share (down 1400% year-over-year) and revenues projected to decline 5% to $67.18 million. With no recent changes in earnings estimate revisions and a Zacks Rank #3 (Hold) rating, analysts question whether the recent rally can sustain.

SkinHealth Systems (Nasdaq: SKIN) announced the European launch of SkinStylus® SteriLock® MicroSystem, a professional micro- and nano-needling device, now available in the UK, Ireland, Germany, France, Spain, and Portugal. The expansion leverages the company's established Hydrafacial distribution network and aims to offer complementary aesthetic solutions to practitioners across the region.